They had $13.2m Cash on Hand at 31/01 with expected burn for the quarter of $6m. I doubt it is a CR, not with pending assay/drill results and not when they could probably get through to late Q2 FY20 without raising funds?
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025